Publications by authors named "Carla Greenbaum"

Claim this Profile
L
Lessons from Prediction and Prevention of Type 1 Diabetes.
Cate Speake, Adam Lacy-Hulbert, James Lord, Carla Greenbaum

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real-world cohort study.
Katherine R Tuttle, Christina L Reynolds, Lindsey M Kornowske, Cami R Jones, Radica Z Alicic, Carla Greenbaum

Lancet Reg Health Am· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Carla J Greenbaum

Diabetologia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
Stephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez, Megan Smithmyer, Christine Bender, Carla J Greenbaum

J Clin Endocrinol Metab· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
Carla J Greenbaum, Gerald T Nepom, Lauren K Wood-Heickman, Diane K Wherrett, Linda A DiMeglio

Diabetes· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Carla J Greenbaum

Diabetes Care· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Carla J Greenbaum

Diabetologia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Carla J Greenbaum

Diabetologia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Carla J Greenbaum

Diabetes Care· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Esther Latres, Carla J Greenbaum, Maria L Oyaski, Colin M Dayan, Helen M Colhoun

Diabetes· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.
Alyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, Darrell M Wilson, Andrea K Steck, Carla J Greenbaum

J Clin Endocrinol Metab· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
Sandra M Lord, Henry T Bahnson, Carla J Greenbaum, David R Liljenquist, John Virostko

PLoS One· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine in Stage 1 Type 1 Diabetes.
Ingrid Libman, Polly J Bingley, Dorothy Becker, Jane H Buckner, Linda A DiMeglio, Carla Greenbaum

Diabetes Care· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes.
Elisa Balmas, Janice Chen, Alex K Hu, Hannah A DeBerg, Mario G Rosasco, Carla J Greenbaum

JCI Insight· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes.
Alyssa Ylescupidez, Henry T Bahnson, Colin O'Rourke, Sandra Lord, Cate Speake, Carla J Greenbaum

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes.
Jeremy R B Newman, S Alice Long, Cate Speake, Carla J Greenbaum, Karen Cerosaletti

Commun Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approval of teplizumab: implications for patients.
Cate Speake, Carla J Greenbaum

Nat Rev Endocrinol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Carla J Greenbaum

Diabetes Care· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent.
Alexandra E Grier, Janet B McGill, Sandra M Lord, Cate Speake, Carla Greenbaum

AACE Clin Case Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, Carla J Greenbaum

Diabetes Care· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis.
Colin O'Rourke, Alyssa Ylescupidez, Henry T Bahnson, Christine Bender, Cate Speake, Carla J Greenbaum

J Clin Endocrinol Metab· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.
Hai Nguyen, David Arribas-Layton, I-Ting Chow, Cate Speake, William W Kwok, Carla J Greenbaum

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function.
Cate Speake, Tania Habib, Katharina Lambert, Christian Hundhausen, Sandra Lord, Carla J Greenbaum

JCI Insight· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment and Retention Strategies for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.
Cemal Yazici, Anne-Marie Dyer, Darwin L Conwell, Elham Afghani, Dana K Andersen, Carla J Greenbaum

Pancreas· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis